ロード中...
Phase 1b Study of New Posaconazole Tablet for Prevention of Invasive Fungal Infections in High-Risk Patients with Neutropenia
Posaconazole tablets, a new oral formulation of posaconazole, can be effective when given as antifungal prophylaxis to neutropenic patients at high risk for invasive fungal infection (e.g., those with acute myelogenous leukemia or myelodysplastic syndrome). Such effectiveness might be specifically i...
保存先:
主要な著者: | , , , , , , , , , , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
American Society for Microbiology
2014
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4187965/ https://ncbi.nlm.nih.gov/pubmed/25049247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03050-14 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|